| Record ID | harvard_bibliographic_metadata/ab.bib.00.20150123.full.mrc:297272398:1364 |
| Source | harvard_bibliographic_metadata |
| Download Link | /show-records/harvard_bibliographic_metadata/ab.bib.00.20150123.full.mrc:297272398:1364?format=raw |
LEADER: 01364cam a2200385uu 4500
001 000388316-7
005 20020606090541.3
008 830215s1982 enk b 00010 eng
010 $a 82148168 //r84
020 $a0950339296 (pbk.) :$c£3.95
035 0 $aocm08957323
035 0 $aocm09281332
040 $aDLC$cDLC
043 $ad------
050 4 $aHD9666.6$b.M46
060 4 $aQV 736.3 M488d 1982
100 1 $aMedawar, Charles.
245 10 $aDrug diplomacy :$bdecoding the conduct of a multinational pharmaceutical company and the failure of a western remedy for the Third World /$cCharles Medawar and Barbara Freese.
260 0 $aLondon :$bSocial Audit,$c[c1982]
300 $avii, 119 p. :$bill. ;$c21 cm.
504 $aBibliography: p. 112-115.
610 20 $aG.D. Searle & Co.
650 2 $aDrug Industry
650 2 $aDeveloping Countries
650 2 $aAntidiarrheals$xadverse effects
650 0 $aPharmaceutical industry$zDeveloping countries$xState supervision.
650 0 $aPharmaceutical industry$xMoral and ethical aspects$zDeveloping countries.
610 22 $aG.D. Searle & Co.
650 0 $aPharmaceutical industry.
651 0 $aDeveloping countries$xInternational business enterprises.
651 2 $aDeveloping countries.
700 1 $aFreese, Barbara.
710 1 $aFreese, Barbara.
988 $a20020608
906 $0DLC